Literature DB >> 24399297

The ubiquitin-specific protease USP15 promotes RIG-I-mediated antiviral signaling by deubiquitylating TRIM25.

Eva-Katharina Pauli1, Ying Kai Chan, Meredith E Davis, Sebastian Gableske, May K Wang, Katharina F Feister, Michaela U Gack.   

Abstract

Ubiquitylation is an important mechanism for regulating innate immune responses to viral infections. Attachment of lysine 63 (Lys(63))-linked ubiquitin chains to the RNA sensor retinoic acid-inducible gene-I (RIG-I) by the ubiquitin E3 ligase tripartite motif protein 25 (TRIM25) leads to the activation of RIG-I and stimulates production of the antiviral cytokines interferon-α (IFN-α) and IFN-β. Conversely, Lys(48)-linked ubiquitylation of TRIM25 by the linear ubiquitin assembly complex (LUBAC) stimulates the proteasomal degradation of TRIM25, thereby inhibiting the RIG-I signaling pathway. Here, we report that ubiquitin-specific protease 15 (USP15) deubiquitylates TRIM25, preventing the LUBAC-dependent degradation of TRIM25. Through protein purification and mass spectrometry analysis, we identified USP15 as an interaction partner of TRIM25 in human cells. Knockdown of endogenous USP15 by specific small interfering RNA markedly enhanced the ubiquitylation of TRIM25. In contrast, expression of wild-type USP15, but not its catalytically inactive mutant, reduced the Lys(48)-linked ubiquitylation of TRIM25, leading to its stabilization. Furthermore, ectopic expression of USP15 enhanced the TRIM25- and RIG-I-dependent production of type I IFN and suppressed RNA virus replication. In contrast, depletion of USP15 resulted in decreased IFN production and markedly enhanced viral replication. Together, these data identify USP15 as a critical regulator of the TRIM25- and RIG-I-mediated antiviral immune response, thereby highlighting the intricate regulation of innate immune signaling.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24399297      PMCID: PMC4008495          DOI: 10.1126/scisignal.2004577

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  41 in total

1.  Arterivirus and nairovirus ovarian tumor domain-containing Deubiquitinases target activated RIG-I to control innate immune signaling.

Authors:  Puck B van Kasteren; Corrine Beugeling; Dennis K Ninaber; Natalia Frias-Staheli; Sander van Boheemen; Adolfo García-Sastre; Eric J Snijder; Marjolein Kikkert
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Inhibition of RIG-I-mediated signaling by Kaposi's sarcoma-associated herpesvirus-encoded deubiquitinase ORF64.

Authors:  Kyung-Soo Inn; Sun-Hwa Lee; Jessica Y Rathbun; Lai-Yee Wong; Zsolt Toth; Keigo Machida; Jing-Hsiung James Ou; Jae U Jung
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

3.  USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma.

Authors:  Pieter J A Eichhorn; Laura Rodón; Alba Gonzàlez-Juncà; Annette Dirac; Magüi Gili; Elena Martínez-Sáez; Claudia Aura; Ignasi Barba; Vicente Peg; Aleix Prat; Isabel Cuartas; Jose Jimenez; David García-Dorado; Juan Sahuquillo; Réné Bernards; José Baselga; Joan Seoane
Journal:  Nat Med       Date:  2012-02-19       Impact factor: 53.440

4.  Conventional protein kinase C-α (PKC-α) and PKC-β negatively regulate RIG-I antiviral signal transduction.

Authors:  Natalya P Maharaj; Effi Wies; Andrej Stoll; Michaela U Gack
Journal:  J Virol       Date:  2011-11-23       Impact factor: 5.103

5.  Linear ubiquitin assembly complex negatively regulates RIG-I- and TRIM25-mediated type I interferon induction.

Authors:  Kyung-Soo Inn; Michaela U Gack; Fuminori Tokunaga; Mude Shi; Lai-Yee Wong; Kazuhiro Iwai; Jae U Jung
Journal:  Mol Cell       Date:  2011-02-04       Impact factor: 17.970

6.  Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity.

Authors:  Wenwen Zeng; Lijun Sun; Xiaomo Jiang; Xiang Chen; Fajian Hou; Anirban Adhikari; Ming Xu; Zhijian J Chen
Journal:  Cell       Date:  2010-04-16       Impact factor: 41.582

7.  Dephosphorylation of the RNA sensors RIG-I and MDA5 by the phosphatase PP1 is essential for innate immune signaling.

Authors:  Effi Wies; May K Wang; Natalya P Maharaj; Kan Chen; Shenghua Zhou; Robert W Finberg; Michaela U Gack
Journal:  Immunity       Date:  2013-03-14       Impact factor: 31.745

8.  Negative role of RIG-I serine 8 phosphorylation in the regulation of interferon-beta production.

Authors:  Estanislao Nistal-Villán; Michaela U Gack; Gustavo Martínez-Delgado; Natalya P Maharaj; Kyung-Soo Inn; Heyi Yang; Rong Wang; Aneel K Aggarwal; Jae U Jung; Adolfo García-Sastre
Journal:  J Biol Chem       Date:  2010-04-20       Impact factor: 5.157

9.  Phosphorylation-mediated negative regulation of RIG-I antiviral activity.

Authors:  Michaela U Gack; Estanislao Nistal-Villán; Kyung-Soo Inn; Adolfo García-Sastre; Jae U Jung
Journal:  J Virol       Date:  2010-01-13       Impact factor: 5.103

10.  USP15 is a deubiquitylating enzyme for receptor-activated SMADs.

Authors:  Masafumi Inui; Andrea Manfrin; Anant Mamidi; Graziano Martello; Leonardo Morsut; Sandra Soligo; Elena Enzo; Stefano Moro; Simona Polo; Sirio Dupont; Michelangelo Cordenonsi; Stefano Piccolo
Journal:  Nat Cell Biol       Date:  2011-09-25       Impact factor: 28.824

View more
  89 in total

1.  RNA Helicase LGP2 Negatively Regulates RIG-I Signaling by Preventing TRIM25-Mediated Caspase Activation and Recruitment Domain Ubiquitination.

Authors:  Kendra M Quicke; Kristin Y Kim; Curt M Horvath; Mehul S Suthar
Journal:  J Interferon Cytokine Res       Date:  2019-06-25       Impact factor: 2.607

2.  USP15 Participates in Hepatitis C Virus Propagation through Regulation of Viral RNA Translation and Lipid Droplet Formation.

Authors:  Shinji Kusakabe; Tatsuya Suzuki; Yukari Sugiyama; Saori Haga; Kanako Horike; Makoto Tokunaga; Junki Hirano; He Zhang; David Virya Chen; Hanako Ishiga; Yasumasa Komoda; Chikako Ono; Takasuke Fukuhara; Masahiro Yamamoto; Masahito Ikawa; Takashi Satoh; Shizuo Akira; Tomohisa Tanaka; Kohji Moriishi; Moto Fukai; Akinobu Taketomi; Sachiyo Yoshio; Tatsuya Kanto; Tetsuro Suzuki; Toru Okamoto; Yoshiharu Matsuura
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

Review 3.  Mechanisms and pathways of innate immune activation and regulation in health and cancer.

Authors:  Jun Cui; Yongjun Chen; Helen Y Wang; Rong-Fu Wang
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 4.  Mechanisms of RIG-I-like receptor activation and manipulation by viral pathogens.

Authors:  Michaela U Gack
Journal:  J Virol       Date:  2014-03-12       Impact factor: 5.103

Review 5.  TRIM Proteins and Their Roles in Antiviral Host Defenses.

Authors:  Michiel van Gent; Konstantin M J Sparrer; Michaela U Gack
Journal:  Annu Rev Virol       Date:  2018-06-27       Impact factor: 10.431

Review 6.  Molecular Mechanisms of Innate Immune Inhibition by Non-Segmented Negative-Sense RNA Viruses.

Authors:  Srirupa Chatterjee; Christopher F Basler; Gaya K Amarasinghe; Daisy W Leung
Journal:  J Mol Biol       Date:  2016-07-31       Impact factor: 5.469

Review 7.  Ubiquitination in the antiviral immune response.

Authors:  Meredith E Davis; Michaela U Gack
Journal:  Virology       Date:  2015-03-07       Impact factor: 3.616

8.  Finding the 'ubiquitous' threads in infection and autoimmune neuroinflammation.

Authors:  Sophia Bardehle; Victoria Rafalski; Katerina Akassoglou
Journal:  Nat Immunol       Date:  2016-12-16       Impact factor: 25.606

9.  Use of focused ultrasonication in activity-based profiling of deubiquitinating enzymes in tissue.

Authors:  Bindu Nanduri; Leslie A Shack; Aswathy N Rai; William B Epperson; Wes Baumgartner; Ty B Schmidt; Mariola J Edelmann
Journal:  Anal Biochem       Date:  2016-09-20       Impact factor: 3.365

10.  USP15 Deubiquitinates TUT1 Associated with RNA Metabolism and Maintains Cerebellar Homeostasis.

Authors:  Junnosuke Nakamura; Chiharu Hamada; Takumi Taketomi; Jaehyun Kim; Sarasa Yano; Tomomi Okajima; Shin-Ichi Kashiwabara; Tadashi Baba; Ban Sato; Tomoki Chiba; Fuminori Tsuruta
Journal:  Mol Cell Biol       Date:  2020-10-13       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.